Location: Greenwich, CT
CIK: 0001596452 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 13, 2020
Total Value: $269M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| HUM | Humana Inc | 27,500 | $10.08M | 3.7% | $366.51 * | $207.12 | +67.9% | Cash Securities | 444859102 |
| HCA | HCA Healthcare Inc | 62,500 | $9.238M | 3.4% | $147.81 * | $121.55 | +15.8% | Cash Securities | 40412C101 |
| CNC | Centene Corp | 135,000 | $8.487M | 3.2% | $62.87 | $52.87 | +18.9% | Cash Securities | 15135B101 |
| BMY | Bristol-Myers Squibb Co | 130,000 | $8.345M | 3.1% | $64.19 * | $45.19 | +12.1% | Cash Securities | 110122108 |
| ELV | Anthem Inc | 27,500 | $8.306M | 3.1% | $302.04 * | $206.30 | +35.0% | Cash Securities | 036752103 |
| CI | Cigna Corp | 40,000 | $8.18M | 3.0% | $204.50 * | $158.28 | +18.2% | Cash Securities | 125523100 |
| THC | Tenet Healthcare Corp | 215,000 | $8.176M | 3.0% | $38.03 | $24.29 | +56.5% | Cash Securities | 88033G407 |
| UNH | UnitedHealth Group Inc | 27,500 | $8.084M | 3.0% | $293.96 * | $217.39 | +22.6% | Cash Securities | 91324P102 |
| BSX | Boston Scientific Corp | 175,000 | $7.914M | 2.9% | $45.22 | $23.58 | +91.7% | Cash Securities | 101137107 |
| UHS | Universal Health Services Inc | 55,000 | $7.89M | 2.9% | $143.45 * | $124.96 | +11.6% | Cash Securities | 913903100 |
| DHR | Danaher Corp | 50,000 | $7.674M | 2.8% | $153.48 * | $93.99 | +41.0% | Cash Securities | 235851102 |
| SNY | Sanofi ADR | 150,000 | $7.53M | 2.8% | $50.20 | $43.18 | +16.3% | Cash Securities | 80105N105 |
| REGN | Regeneron Pharmaceuticals Inc | 20,000 | $7.51M | 2.8% | $375.50 | $359.31 | +3.9% | Cash Securities | 75886F107 |
| ISRG | Intuitive Surgical Inc | 12,500 | $7.389M | 2.7% | $591.12 * | $157.72 | +24.9% | Cash Securities | 46120E602 |
| VRTX | Vertex Pharmaceuticals Inc | 32,500 | $7.116M | 2.6% | $218.95 | $126.74 | +72.8% | Cash Securities | 92532F100 |
| MRK | Merck & Co Inc | 75,000 | $6.821M | 2.5% | $90.95 * | $48.79 | +47.1% | Cash Securities | 58933Y105 |
| BMRN | BioMarin Pharmaceutical Inc | 80,000 | $6.764M | 2.5% | $84.55 | $81.35 | +3.9% | Cash Securities | 09061G101 |
| LLY | Eli Lilly & Co | 50,000 | $6.572M | 2.4% | $131.44 * | $81.68 | +49.7% | Cash Securities | 532457108 |
| GRFS | Grifols SA ADR | 275,000 | $6.405M | 2.4% | $23.29 | $20.65 | +12.8% | Cash Securities | 398438408 |
| AZN | AstraZeneca PLC ADR | 125,000 | $6.233M | 2.3% | $49.86 | $40.88 | — | Cash Securities | 046353108 |
| AMGN | Amgen Inc | 25,000 | $6.027M | 2.2% | $241.08 * | $182.69 | +9.7% | Cash Securities | 031162100 |
| BIIB | Biogen Inc | 20,000 | $5.935M | 2.2% | $296.75 | $277.46 | +6.9% | Cash Securities | 09062X103 |
| BAX | Baxter International Inc | 70,000 | $5.853M | 2.2% | $83.61 * | $52.74 | +40.9% | Cash Securities | 071813109 |
| TMO | Thermo Fisher Scientific Inc | 17,500 | $5.685M | 2.1% | $324.86 | $227.67 | +40.5% | Cash Securities | 883556102 |
| BIO | Bio-Rad Laboratories Inc | 15,000 | $5.55M | 2.1% | $370.00 | $258.11 | +43.4% | Cash Securities | 090572207 |
| IQV | IQVIA Holdings Inc | 35,000 | $5.408M | 2.0% | $154.51 | $147.68 | +4.6% | Cash Securities | 46266C105 |
| ZTS | Zoetis Inc | 40,000 | $5.294M | 2.0% | $132.35 * | $115.45 | +9.0% | Cash Securities | 98978V103 |
| SYK | Stryker Corp | 25,000 | $5.249M | 1.9% | $209.96 * | $164.07 | +20.0% | Cash Securities | 863667101 |
| ZBH | Zimmer Biomet Holdings Inc | 35,000 | $5.239M | 1.9% | $149.69 * | $131.26 | +5.4% | Cash Securities | 98956P102 |
| ABT | Abbott Laboratories | 60,000 | $5.212M | 1.9% | $86.87 * | $44.19 | +76.8% | Cash Securities | 002824100 |
| MDT | Medtronic PLC | 45,000 | $5.105M | 1.9% | $113.44 * | $80.53 | +19.4% | Cash Securities | G5960L103 |
| JNJ | Johnson & Johnson | 35,000 | $5.105M | 1.9% | $145.86 * | $114.10 | +8.0% | Cash Securities | 478160104 |
| ABBV | AbbVie Inc | 50,000 | $4.427M | 1.6% | $88.54 * | $64.63 | +6.8% | Cash Securities | 00287Y109 |
| — | Laboratory Corp of America Ho | 25,000 | $4.229M | 1.6% | $169.16 | $158.69 | — | Cash Securities | 50540R409 |
| ALGN | Align Technology Inc | 15,000 | $4.186M | 1.6% | $279.07 | $249.35 | +11.9% | Cash Securities | 016255101 |
| SNN | Smith & Nephew PLC | 75,000 | $3.605M | 1.3% | $48.07 | $45.13 | +6.5% | Cash Securities | 83175M205 |
| EW | Edwards Lifesciences Corp | 15,000 | $3.499M | 1.3% | $233.27 * | $58.71 | +32.4% | Cash Securities | 28176E108 |
| INCY | Incyte Corp | 40,000 | $3.493M | 1.3% | $87.33 | $80.34 | +8.7% | Cash Securities | 45337C102 |
| ILMN | Illumina Inc | 10,000 | $3.317M | 1.2% | $331.70 * | $303.09 | +6.5% | Cash Securities | 452327109 |
| DGX | Quest Diagnostics Inc | 27,500 | $2.937M | 1.1% | $106.80 * | $86.79 | +9.1% | Cash Securities | 74834L100 |
| SRPT | Sarepta Therapeutics Inc | 22,500 | $2.903M | 1.1% | $129.02 | $89.74 | +43.8% | Cash Securities | 803607100 |
| AVTR | Avantor Inc | 150,000 | $2.723M | 1.0% | $18.15 | $15.92 | +14.0% | Cash Securities | 05352A100 |
| ALC | Alcon Inc | 45,000 | $2.546M | 0.9% | $56.58 | $59.15 | -5.7% | Cash Securities | H01301128 |
| — | Hill-Rom Holdings Inc | 19,900 | $2.259M | 0.8% | $113.52 | $104.92 | — | Cash Securities | 431475102 |
| — | Seattle Genetics Inc | 19,500 | $2.228M | 0.8% | $114.26 | $70.34 | — | Cash Securities | 812578102 |
| — | Bluebird Bio Inc | 20,000 | $1.755M | 0.7% | $87.75 | $87.75 | — | Cash Securities | 09609G100 |
| CRSP | CRISPR Therapeutics AG | 25,000 | $1.523M | 0.6% | $60.92 | $54.60 | +11.6% | Cash Securities | H17182108 |
| — | Blueprint Medicines Corp | 18,520 | $1.484M | 0.6% | $80.13 | $82.42 | — | Cash Securities | 09627Y109 |
| — | Sage Therapeutics Inc | 15,000 | $1.083M | 0.4% | $72.20 | $137.87 | — | Cash Securities | 78667J108 |
| SPY | PUT - SPY 500 @ 318 EXP 01/17/20 | 5,000 | $825K | 0.3% | $165.00 | — | — | Put | 78462F103 |